Life sciences startups are popping up — and looking for money — in the Research Triangle Park section of North Carolina, says an article from today’s The News & Observer. “At least […]
Cliff Notes to the Times’ Diagnostics Special Section
Yesterday’s New York Times had a special section — a “user’s guide” — on diagnostic testing. It covers asthma, bone disease, cancer, heart disease, obesity, diabetes, AIDS and glaucoma. Don’t have time […]
High Hopes for New Prostate-Cancer Test
Results released today from a study of a new test for prostate cancer have raised spirits in the medical community and at the private Seattle firm that discovered it. Onconome‘s blood test measures […]
Biomoda Hopes Marketing Will Boost Licensing and Sales
Biomoda, an Albuquerque, NM, maker of cancer diagnostics, announced today that it has hired Synergestic Marketing to help “accelerate licensing development and sales relationships with customers domestically and worldwide,” according to Biomoda’s president, […]
NeoGenomics and Power3 Form CRO
NeoGenomics, a Fort Meyers, FL-based lab that specializes in cancer diagnostic testing, announced on Wednesday that it was teaming up with protein biomarker maker Power3 Medical Products to form a joint venture […]
Three Device Makers Field IPOs
Three venture-backed medical device firms raised more than $400 million through IPOs last quarter, Red Herring reports. Topping the list of money makers was Sunnyvale, CA-based Accuray, maker of the CyberKnife Robotic […]
North American Scientific Poaches Sanarus Chief
Chatsworth, CA-based North American Scientific announced yesterday the appointment of John Rush as president and CEO. The med tech company, which makes radioisotope products for the treatment of cancer, lured Rush from Sanarus Medical of Pleasanton, […]
